Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Dengue Treatment Market Growth Performance Trended Historically, And What Lies Ahead?
In recent times, there has been a swift expansion in the dengue treatment market size. This market is projected to rise from $2.1 billion in 2024 to $2.34 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 11.6%. The surge experienced during the historical period is a result of enhancements in diagnostic instruments, the work of government bodies and NGOs, epidemiological monitoring systems, substantial r&d investments, and efforts towards educating the community.
In the following years, a quick expansion is projected for the dengue treatment market, with anticipated growth to reach$3.6 billion by 2029, reflecting a compound annual growth rate (CAGR) of 11.3%. Factors contributing to this escalating growth in the forecast period could be associated with the advent of universal vaccines, increased accessibility to vaccines, collaborations between public and private sectors, surge in telemedicine, and upgrades in policy framework. Predominant trends marker during the forecast period are expected to be the emergence of next-gen dengue vaccines, AI-driven drug discovery, intelligent contact tracing instruments, printing of vaccines using 3D technology, and the application of CRISPR in targeting viruses.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20745&type=smp
Which Primay Drivers Are Accelerating Growth in the Dengue Treatment Market?
The increase in cases of dengue is expected to stimulate the development of the dengue treatment market. Dengue, a viral infection transmitted by mosquitoes, presents with symptoms similar to the flu, but can escalate into serious complications if not managed in time. The augmentation in dengue cases is largely due to mounting urbanization, climate conditions conducive to mosquito breeding, insufficient pest control measures, and increase in population in susceptible areas. Timely medical intervention offered by dengue treatment reduces the occurrence rate of the disease by alleviating severe symptoms, averting complications, and controlling the spread of the illness through improved patient results and heightened public health knowledge. For example, a 2023 report from the US-based government agency, Centers for Disease Control and Prevention, stated that there was a surge in dengue fever cases in the Americas, with over 4.6 million cases and around 4,000 deaths, which represented a 13% increase from 2022 and a significant spike from prior years. Consequently, the escalating dengue case rate is fuelling the expansion of the dengue treatment market.
Which Primary Segments of the Dengue Treatment Market Are Driving Growth and Industry Transformations?
The dengue treatmentmarket covered in this report is segmented –
1) By Type: Vaccines; Acetaminophen
2) By Route Of Administration: Parenteral; Oral
3) By Drug Class: Nsaids; Antibiotics; Corticosteroids
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
5) By End User: Hospital; Specialty Clinics; Home Healthcare
Subsegments:
1) By Vaccines: Live Attenuated Vaccines; Recombinant Vaccines; Inactivated Vaccines
2) By Acetaminophen: Oral Acetaminophen; Intravenous Acetaminophen
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=20745&type=smp
Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Dengue Treatment Market?# Market?
Asia-Pacific was the largest region in the dengue treatment in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dengue treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Technological Trends Are Reshaping the Dengue Treatment Industry Dynamics?
Primary players in the dengue treatment market are concentrating on advancing solutions like broad-spectrum antiviral medications to improve efficacy of treatment, lessen the severity of the disease, and tackle manifold dengue virus serotypes concurrently. Broad-spectrum antiviral medications denote drugs that are potent against an array of viruses, not just one specific virus. For instance, Hyundai Pharmaceutical Co. Ltd., a pharmaceutical products company based in South Korea, in September 2024, introduced XAFTY. This pioneering broad-spectrum antiviral is designed to cure multiple viral infections, including dengue fever and COVID-19. It boasts unique attributes such as an innovative medication that boosts the absorption and potency of niclosamide, clinically proven safety and efficacy, the capacity to target an assortment of RNA viruses, ensuring flexibility against possible future threats, and a swift response capability that enables a speedy delivery to areas facing public health emergencies.
View the full report here:
https://www.thebusinessresearchcompany.com/report/dengue-treatment-global-market-report
What Parameters Are Used to Define the Dengue Treatment Market?
Dengue treatment refers to the medical management and supportive care provided to individuals infected with the dengue virus, transmitted by Aedes mosquitoes. Dengue treatment utilizes supportive care measures, such as fever management with paracetamol, hydration through oral or intravenous fluids, and close monitoring for complications like bleeding or shock, ensuring timely intervention to aid recovery.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20745
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model